PanTera

Mol, Belgium

PanTera produces actinium-225 for personalized cancer treatment and radiopharmaceuticals.

$110.3M raised

Sep 2024

Series A

Top Investors

EQT Life SciencesKurma PartnersEurazeoPMVKorys

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has PanTera raised?

PanTera has raised $110.3M in total funding. The most recent round was Series A. The last funding was announced in September 2024.

Who are PanTera's investors?

PanTera's investors include EQT Life Sciences, Kurma Partners, Eurazeo, PMV, Korys.

Where is PanTera headquartered?

PanTera is headquartered in Mol, Belgium.

What does PanTera do?

PanTera produces actinium-225 for personalized cancer treatment and radiopharmaceuticals.

What stage is PanTera at?

PanTera is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 11, 2024.

MLA

"PanTera — Funding & Investors." VCBacked, September 11, 2024, https://www.vcbacked.co/company/pantera. Accessed June 9, 2026.

APA

VCBacked. (2024). PanTera — Funding & Investors. Retrieved June 9, 2026, from https://www.vcbacked.co/company/pantera

Wikipedia (cite web)

{{cite web |title=PanTera — Funding & Investors |url=https://www.vcbacked.co/company/pantera |website=VCBacked |access-date=June 9, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 11, 2024.